ST
NWBO

Spot Trading’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Spot Trading’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,000
Closed -$64K – 4544
2015
Q4 		$64K Buy
+20,000
New +$96.2K ﹤0.01% 2971
2015
Q2 		– Sell
-111,200
Closed -$820K – 4633
2015
Q1 		$820K Buy
+111,200
New +$748K 0.01% 1746
2014
Q4 		– Sell
-10,800
Closed -$54K – 4865
2014
Q3 		$54K Hold
10,800
– – ﹤0.01% 3748
2014
Q2 		$72K Buy
+10,800
New +$68.7K ﹤0.01% 3818

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spot Trading's NWBO Position: Q1 2016 in Review

Spot Trading sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2016, closing a stake of 50 shares.

Spot Trading first reported a position in NWBO in Q2 2014 and held it in 4 quarters. The position peaked at $37K in Q2 2015. 74 funds tracked by Wall St. Rank hold NWBO as of Q1 2016.

  • Spot Trading reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 50 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2016.
  • Spot Trading first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 4 quarters.
  • Spot Trading's Northwest Biotherapeutics, Inc. Common stock position peaked at $37K in Q2 2015.
  • 74 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.